NL-OMON24739招募中不适用
Treatment protocol of the first international study for Langerhans Cell Histiocytosis in Adults
VU University Medical Center Amsterdam,Department of Hematology0 个研究点目标入组 1,200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,200
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. definitive diagnosis of LCH
- •2. no prior cytoreductive treatment for LCH
排除标准
- •1. patients with severe impairment of clinical condition including severely impaired pulmonary function, long term oxygen therapy or cor pulmonale.
- •2. treatment with immune suppressive agents and/or bisphosphonates within 4 weeks from baseline evaluation 3. pregnancy
研究者
相似试验
尚未招募
2 期
Treatment Protocol of the First International Study of Langerhans Cell Histiocytosis in adultsLCH1004795410018865Langerhans Cell HistiocytosisNL-OMON30781Vrije Universiteit Medisch Centrum20
进行中（未招募）
不适用
Treatment protocol of the second international study for hemophagoocytic lymphohistiocytosis (HLH) - HLH-2004EUCTR2006-002391-17-ITAZIENDA DI RILIEVO NAZIONALE E DI ALTA SPECIALIZZAZIONE OSPEDALE CIVICO E BENFRATELLI, G.DI CRISTINA E M.ASCOLI400
已完成
不适用
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage TrialIntracerebral HemorrhageStrokeHypertensionNCT00716079The George Institute2,839
进行中（未招募）
不适用
First international trial for diagnosia nd treatment of langerhans cell histiocytosis in adults - LCH-A1angerhans cell histiocytosisMedDRA version: 9.1Level: HLTClassification code 10020118Term: HistiocytosesEUCTR2006-002392-40-ITAZ. DI RILIEVO NAZ. E DI ALTA SPECIALIZZAZIONE OSP. CIVICO E BENFRATELLI, G.DI CRISTINA E M.ASCOLI250
已完成
3 期
Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High MyopiaChoroidal Subfoveal/Juxtafoveal Neovascularization in High MyopiaNCT01716026Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA66